Founded Year

2014

About MediMergent

MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.

MediMergent Headquarter Location

9210 Corporate Boulevard Suite 100

Rockville, Maryland, 20850,

United States

301-388-5888

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

MediMergent's Products & Differentiation

See MediMergent's products and how their products differentiate from alternatives and competitors

  • NMSOAP

    National Medication Safety Outcomes and Adherence Platform, the Company's core technology, includes patient outcome surveys, dashboards to monitor program activities. Bi-directional portals to upload medical records, pharmacy, claims and wearable devices via custom APIs. Turn-key virtual management platform; serves as an early-warning system for adverse events. Backend analytics integrate multi-source RWD.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing MediMergent

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MediMergent is included in 1 Expert Collection, including Precision Medicine Tech Market Map.

P

Precision Medicine Tech Market Map

160 items

This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.

Latest MediMergent News

My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19

Apr 19, 2021

04/19/2021 | 12:02am EDT Message : *Required fields As COVID vaccine safety-related issues escalate, stakeholders implement digital strategies to communicate to leery consumers the risks/benefits of vaccination. MediMergent - The Real-World Evidence Company, in collaboration with MedRespond , an AI-driven Conversational Technology company and TalkBackTime , a video-based consumer engagement company, launch My Vaccine Program (MVP), a fully-integrated, cloud-based platform that engages and educates consumers related to their COVID-19 vaccine experiences. Sandra Garrett, CEO of MediMergent states: “The MVP engages directly with consumers and captures their attitudes and behaviors related to their health/disease and treatment, in order to improve outcomes. To address vaccine hesitancy, consumers need accurate information regarding the risks/benefits and how people “just like me”, with similar health profiles, react to the vaccine. The MVP builds a supportive community, especially for the medically underserved and ethnic and racial minorities.” “Deploying a library of over 250 learning modules, we invite patients to open a dialogue with a virtual healthcare expert”, says Virginia Pribanic, CEO of MedRespond. “The platform anticipates questions using AI-based algorithms and delivers personalized, patient-centered responses. We explore vaccine hesitancy, validate patients’ concerns, and present a fact-based discussion supporting the patients’ decision making.” TalkBackTime obtains consumer feedback on pre-defined issues like vaccine hesitancy, and produces candid videos which resonate with “people like me” through actual speech patterns, dialects, tone, mode and body language. “Our analytics profile responses by age, sex, race, ethnicity, location” says Allan Horlick, Managing Partner. “These videos add a qualitative dimension to the quantitative data we are collecting in the MVP”. Consumers enroll in the My Vaccine Program and complete surveys, across eight weeks, about their vaccine experiences. They enroll in the program via an application to their administering pharmacy, vaccination center, or their employee health and wellness programs. MediMergent’s platform monitors post-vaccination safety surveillance, tracks potential side effects and produces de-identified data that can be reported to multiple stakeholders, including the consumers themselves. These multi-faceted engagements empower consumers with relevant data, within their own community, enabling them to move from hesitancy to vaccination. View source version on businesswire.com: https://www.businesswire.com/news/home/20210418005020/en/ © Business Wire 2021

  • When was MediMergent founded?

    MediMergent was founded in 2014.

  • Where is MediMergent's headquarters?

    MediMergent's headquarters is located at 9210 Corporate Boulevard, Rockville.

  • Who are MediMergent's competitors?

    Competitors of MediMergent include Syapse and 4 more.

  • What products does MediMergent offer?

    MediMergent's products include NMSOAP and 4 more.

  • Who are MediMergent's customers?

    Customers of MediMergent include FDA and Pharmacies.

You May Also Like

Holmusk Logo
Holmusk

Holmusk is a data science and digital therapeutics company with a global presence that is dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Holmusk's proprietary technology powers data-driven medicine that leverages analytic and digital tools to address the unmet need in healthcare and pharma-life science.

V
Verantos

Verantos specializes in high accuracy real-world evidence (RWE) generation. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use. The Verantos RWE platform leverages data science and artificial intelligence along with advanced data sources to generate RWE capable of supporting clinical assertions.

Verana Health Logo
Verana Health

Verana Health assembles clinical databases in medicine to empower physicians and accelerate research for patients. The databases produce drug lifecycle and medical practice insights.

M
Mango Sciences

Mango Sciences is an emerging market data science company that connects underrepresented patients to precision medicine. The company's platform utilizes AI analytics to transform deep clinical data into key insights. It is based in Boston, Massachusetts.

Semalytix Logo
Semalytix

Semalytix offers pharmaceutical companies an AI-powered data tool to better understand real-world patient experiences. Its flagship product, dubbed "Pharos", is a patient research tool that pulls in and cleans up various unstructured public data -- such as blogs, forums, social media etc. -- and then applies algorithms to deliver real-time patient insights into unmet needs, treatment experience, and how severely a disease impacts the lives of those who suffer from it.

Validic Logo
Validic

Motivation Science is the developer of Validic, a digital health platform that provides a simple connection to secure, standardized data from specialized digital health technologies, such as wellness applications, wearables, fitness equipment and clinical devices.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.